Gables Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Gables Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Hold	60	–	–	﹤0.01%	387
2026 Q1	$10.1K	Hold	60	–	–	﹤0.01%	364
2025 Q4	$10.1K	Hold	60	–	–	﹤0.01%	356
2025 Q3	$8.66K	Hold	60	–	–	﹤0.01%	370
2025 Q2	$7.59K	Hold	60	–	–	﹤0.01%	373
2025 Q1	$7.67K	Hold	60	–	–	﹤0.01%	371
2024 Q4	$7.93K	Hold	60	–	–	﹤0.01%	370
2024 Q3	$8.74K	Hold	60	–	–	﹤0.01%	373
2024 Q2	$8.24K	Sell	60 -90	-60%	-$12K	﹤0.01%	336
2024 Q1	$20.6K	Hold	150	–	–	0.01%	270
2023 Q4	$20.4K	Hold	150	–	–	0.01%	259
2023 Q3	$18.3K	Hold	150	–	–	0.01%	251
2023 Q2	$19K	Hold	150	–	–	0.01%	255
2023 Q1	$19.4K	Hold	150	–	–	0.01%	255
2022 Q4	$19.7K	Hold	150	–	–	0.01%	246
2022 Q3	$18K	Hold	150	–	–	0.01%	243
2022 Q2	$18K	Hold	150	–	–	0.01%	259
2022 Q1	$20K	Hold	150	–	–	0.01%	258
2021 Q4	$23K	Hold	150	–	–	0.01%	252
2021 Q3	$24K	Hold	150	–	–	0.02%	249
2021 Q2	$25K	Hold	150	–	–	0.02%	247
2021 Q1	$23K	Sell	150 -6	-4%	-$953	0.01%	276
2020 Q4	$24K	Hold	156	–	–	0.01%	258
2020 Q3	$21K	Hold	156	–	–	0.01%	264
2020 Q2	$21K	Hold	156	–	–	0.01%	248
2020 Q1	$17K	Hold	156	–	–	0.01%	258
2019 Q4	$19K	Hold	156	–	–	0.01%	255
2019 Q3	$16K	Hold	156	–	–	0.01%	266
2019 Q2	$17K	Hold	156	–	–	0.01%	250
2019 Q1	$17K	Hold	156	–	–	0.01%	254
2018 Q4	$15K	Hold	156	–	–	0.01%	252
2018 Q3	$19K	Hold	156	–	–	0.01%	248
2018 Q2	$17K	Buy	+156	New	+$16.7K	0.01%	255

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Gables Capital Management's IBB Position: Q2 2026 in Review

Gables Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 60 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

Gables Capital Management first reported a position in IBB in Q2 2018 and has held it in 33 quarters since. The position peaked at $25K in Q2 2021. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Gables Capital Management held 60 shares of iShares Biotechnology ETF worth $11.4K as of Q2 2026.
Gables Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Gables Capital Management's portfolio in Q2 2026, its #387 holding.
Gables Capital Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 33 quarters since.
Gables Capital Management's iShares Biotechnology ETF position peaked at $25K in Q2 2021.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.